GlassScriptPhysician profile
Daniel Fassett
NPI 1205902442
$48,645.03
in general payments reported to CMS, 2019-2025
25 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $21K · 2021: $121 · 2022: $8,130 · 2023: $2,613 · 2024: $469 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,250 · Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,250.00 |
| Food and Beverage | $941.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Implant Systems, LLC | $41,525.64 | 2019-2023 | Ennovate |
| Aesculap, INC. | $5,588.36 | 2022 | |
| Depuy Synthes Sales INC. | $291.11 | 2022-2024 | Expedium Verse, Expedium, Symphony |
| Icotec Medical INC. | $180.47 | 2021-2022 | |
| Stryker Corporation | $163.75 | 2024 | Monterey Al |
| Aesculap Ag | $156.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $111.19 | 2022 | |
| Theragen, INC. | $69.54 | 2022-2023 | Actastim-S |
| Highridge Medical LLC | $69.34 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Reel Surgical, INC. | $65.36 | 2024 | |
| Ebi, LLC | $63.78 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Boston Scientific Corporation | $53.90 | 2024 | |
| Zimvie INC. | $36.88 | 2022-2024 | |
| Orthofix Medical, INC. | $30.76 | 2022 | |
| Next Science LLC | $29.95 | 2024 | Xperience, Surgx, Blastx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $29.06 | 2025 | Restrata Wound Matrix |
| Molnlycke Health Care US, LLC | $24.79 | 2023 | Mepilex Border Post-Op Ag |
| Biotronik INC. | $24.43 | 2022 | |
| Ossdsign USA Incorporated | $24.00 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $21.43 | 2024 | Iovera, Zilretta, Exparel |
| Abbott Laboratories | $19.41 | 2022 | |
| Radius Health, INC. | $17.14 | 2022 | |
| Convatec INC. | $16.52 | 2025 | |
| Medtronic USA, INC. | $16.40 | 2020 | |
| Medtronic, INC. | $15.67 | 2023 | Accurian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fassett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.